Specialities
MedTalks TV
.webp)
.webp)
Recent Medbytes
.png)
Mounjaro® (tirzepatide) is a once-weekly injectable medication, FDA-approved for type 2 diabetes, that helps improve blood sugar control. While primarily indicated for diabetes, Mounjaro is also p... Read More
.png)
Key Similarities Both treat type 2 diabetes and promote weight loss. These are once-weekly injections: mounjaro (tirzepatide) and semaglutide (Ozempic). Both lower a... Read More
.png)
Mounjaro is approved for type 2 diabetes, where it helps control blood sugar and also supports weight loss in many patients. Starting and Titration Providers usually begin with a low dose to li... Read More
.png)
Price and AccessThe cost of Mounjaro® (tirzepatide) varies by country, insurance coverage, and pharmacy availability. In the U.S., it can be expensive without insurance, though some plans may cove... Read More
What Is Mounjaro (Tirzepatide)?Mounjaro is the brand name for tirzepatide, a once-weekly tirzepatide injection designed to improve blood sugar in type 2 diabetes while also supporting meaningful weigh... Read More
Meet Our Faculty
DR.KK AGGARWAL
Cardiology
DR.SANJAY KALRA
Diabetes & Endocrinology
DR.SURYA KANT TRIPATHI
Pulmonary Medicine
DR.SHASHANK JOSHI
Cardiology
DR.RAJESH MALHOTRA
Orthopedics
DR.PRAMOD KUMAR JULKA
Oncology
DR.NAGESHWAR REDDY
Gastroenterology
DR.ANIL GANJOO
Dermatology
DR.KK AGGARWAL
Cardiology
DR.SIMON NADEL
Pediatrics
DR.AVIJIT BHATTACHARYA
Internal Medicine
DR.RAYMOND DOMINIC SAVIO
Critical Care
DR.ANIRBAN HOM CHOUDHURI
Critical Care
DR.K SUBBA REDDY
Critical Care
DR.PRADEEP RANGAPPA
Critical Care
